Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients
Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients
- 11/09/2023
- 80 samples
- DAC: EGAC00001003435
- Technology: unspecified
COVID-19 Severity First Wave of Infection for Severe Patients in Madrid
We performed low-coverage whole genome sequencing of 80 samples (80 individuals) hospitalised due to COVID-19 during the first wave of infection in Madrid between March/June 2020. All patients had been confirmed by PCR and their phenotypes annotated using a purposely built controlled vocabulary. DUO:0000006 health/medical/biomedical research and clinical care DUO:0000018 not-for-profit use only DUO:0000020 collaboration required
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001007573 | Other |
